DAXXIFY® | Scranton, PA
The Next Generation of Ageless Beauty
The Next Generation of Ageless Beauty
At Abington Center Medi Spa near Scranton, Pennsylvania, we understand that you may seek facial treatments that offer natural-looking and long-lasting results. That’s why we’re excited to introduce Daxxify®—a game-changing solution specifically designed for treating frown lines. Unlike traditional toxin injectables that may require frequent touch-ups, Daxxify® offers a unique, peptide-powered formula that can last up to twice as long.
We know you’re busy juggling career, family, and self-care, and frequent spa visits may not fit your schedule. With Daxxify®, clinical studies have shown that at least 50% of patients experienced minimal to no frown lines for twice as long as Botox post-treatment. Some even reported improvements lasting as long as 9 months. Imagine the convenience of needing as few as two treatments a year to maintain a smoother, more youthful appearance!
Daxxify® has garnered attention from various media outlets, earning praise for its long-lasting effects—some reports even claim it lasts nearly double the time of other botulinum toxin options. So, if you’re looking for a treatment that aligns with your desire for natural, enduring results, Daxxify® could be your perfect solution.
What is DAXXIFY®?
Daxxify, also known as Daxi or daxibotulinumtoxinA-lanm, is an FDA-approved neuromodulator used for the treatment of wrinkles and severe frown lines. It’s a relatively new addition to the world of aesthetic treatments, joining other well-known neuromodulators like Botox, Dysport, Xeomin, and Jeuveau. What sets Daxxify apart is its innovative peptide exchange technology, which allows it to last longer at the neuromuscular junction where it’s injected.
The Only Vegan Toxin Approved by the FDA
Unlike traditional neuromodulators that contain animal proteins or human albumin, Daxxify is formulated without these components, making it unique in its category. This formulation allows Daxxify to stay tightly bound, providing longer-lasting results than other treatments. It’s particularly popular among those who have noticed that their Botox treatments seem to be fading faster than usual.
Benefits of Daxxify
- Longer-Lasting Results: Daxxify offers an extended duration of 6-9 months, reducing the frequency of maintenance treatments.
- Unique Formulation: The specialized protein in Daxxify’s formulation prolongs its effects, setting it apart from other neuromodulators like Botox.
- FDA-Approved: Daxxify has received FDA approval for its safety and efficacy in treating glabellar lines, also known as frown lines.
- Fewer Treatments Needed: Due to its longer-lasting results, patients require fewer sessions, making it a convenient option for those with busy schedules.
- Potential Cost-Effectiveness: Although the per-unit cost is higher, the longer duration may make Daxxify more cost-effective in the long run.
- Reduced Environmental Impact: Fewer treatment sessions mean less waste from medical supplies like needles and syringes, contributing to environmental sustainability.
- Innovative Technology: Daxxify employs peptide exchange technology, representing a significant advancement in the field of neuromodulators.
- Targeted Treatment: While currently FDA-approved for glabellar lines, Daxxify’s effectiveness in this area makes it a strong choice for those specifically looking to treat frown lines.
- Newer Option: As a recently approved treatment, Daxxify brings a fresh approach to the world of neuromodulators, offering an alternative to established options like Botox.
- Safety Profile: Clinical trials have shown Daxxify to have a safety profile similar to other neuromodulators, making it a reliable choice for wrinkle treatment.
How is Daxxify Different from Botox?
Daxxify and Botox serve as muscle-relaxing neuromodulators, but they differ in key aspects. Daxxify offers longer-lasting results of 6-9 months compared to Botox’s 3-4 months, thanks to its unique protein formulation. While Botox is FDA-approved for multiple types of facial lines, Daxxify is currently approved only for treating glabellar lines. Regarding dosage, Daxxify requires a minimum of 40 units, double that of Botox’s 20 units for the same area. Although Botox has been in the market since 2002, Daxxify, approved in 2022, is quickly gaining popularity for its extended efficacy. Daxxify could be more cost-effective in the long run due to fewer required treatments per year.
Daxxify Injections near Scranton, PA
Discover a rejuvenated you at Abington Center Medi Spa, conveniently located in Clarks Summit, just a short drive from Scranton, PA. As a leading name in aesthetic treatments, we’re thrilled to offer the revolutionary Daxxify injections administered by our team of certified injectors. Daxxify is the latest FDA-approved neuromodulator that promises longer-lasting results, reducing the appearance of frown lines for 2x as long as Botox. With its unique formulation and extended efficacy, Daxxify is rapidly becoming the go-to choice for those seeking a more enduring solution to facial aging. Trust your beauty to the experts; choose Abington Center Medi Spa for a transformative, long-lasting approach to wrinkle treatment. Contact us today for a free consultation!
